Industry

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Electric Wheelchair Market Forecast 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The Saudi Arabia Electric Wheelchair Market is anticipated to grow to US$ 97.49 million by 2033, from US$ 45.94 million in 2024 at a CAGR of 8.72% during 2025 to 2033. Expansion is fueled by growing geriatric and disabled … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Clinical Diagnostics Outlook, 2025” report has been added to ResearchAndMarkets.com’s offering. This research service provides a global outlook for the clinical diagnostics market, along with a 5-year revenue forecast from 2025 to 2030. To succeed in 2025 and beyond, companies must act with agility, invest in high-value areas, and prioritize innovation. Those that … [Read more…]

BOSTON–(BUSINESS WIRE)–Symmetrical Health, LLC, doing business as Cimilre Breast Pumps, announced today that the Centers for Medicare & Medicaid Services (CMS) has established a new HCPCS Level II code A4288, “Valve for breast pump, replacement.” This decision follows a formal request submitted by Cimilre, spearheaded by Jacqui Penda, CLC, to recognize replacement valves as essential … [Read more…]

SEATTLE–(BUSINESS WIRE)–Access to Advanced Health Institute (AAHI), a global leader in translating high-impact science into scalable, field-ready vaccine solutions, today announced an exciting new partnership with Quratis, a premier biotechnology company and advanced Contract Development and Manufacturing Organization (CDMO). This collaboration marks a pivotal step forward in breaking through barriers in global health equity around … [Read more…]

BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in a fireside chat at the Wells Fargo Healthcare Conference in Boston, Massachusetts, on … [Read more…]

DALLAS–(BUSINESS WIRE)–Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Mother Earth Labs, Inc. to a Private Buyer. The acquisition closed August 4, 2025. Headquartered in San Antonio, Texas, Mother Earth Labs, Inc. is a wellness-focused nutritional supplement company committed to harnessing the power … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “United States Personalized Medicine Market – Genomic Trends & Forecast 2025-2033” report has been added to ResearchAndMarkets.com’s offering. United States Personalized Medicine Market is expected to reach US$ 307.04 billion by 2033 from US$ 169.56 billion in 2024, with a CAGR of 6.82% from 2025 to 2033 Advances in next-generation sequencing, rising patient … [Read more…]

Leader in mRNA therapeutics strengthens clinical development expertise with globally recognized oncology innovator BOSTON–(BUSINESS WIRE)–Strand Therapeutics, the leader in programmable mRNA medicines, today announced the appointment of Jason J. Luke, MD, FACP, as Chief Medical Officer. Dr. Luke, an internationally recognized physician-scientist in cancer immunotherapy, brings decades of clinical research, translational science, and leadership experience … [Read more…]

ATLANTA–(BUSINESS WIRE)–Healthcare remains the most targeted industry for cyberattacks, with third-party suppliers implicated in the majority of major breaches. In fact, supplier-related incidents accounted for over 55% of healthcare breaches in 2024, and the average cost of a healthcare data breach exceeded $10 million. For organizations entrusted with protected health information (PHI) and critical patient … [Read more…]

— In the Largest Clinical Trial Conducted in Autoimmune PAP, Molgramostim Inhalation Solution (Molgramostim) Reduced Surfactant Burden and Improved Pulmonary Gas Transfer, Respiratory Health-Related Quality of Life, and Patient Functionality — LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced that the results from the … [Read more…]